The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

PDSS2  -  prenyl (decaprenyl) diphosphate synthase,...

Homo sapiens

Synonyms: All-trans-decaprenyl-diphosphate synthase subunit 2, C6orf210, COQ10D3, Candidate tumor suppressor protein, DLP1, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of PDSS2

 

High impact information on PDSS2

 

Biological context of PDSS2

 

Physical interactions of PDSS2

 

Other interactions of PDSS2

References

  1. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. L??pez, L.C., Schuelke, M., Quinzii, C.M., Kanki, T., Rodenburg, R.J., Naini, A., Dimauro, S., Hirano, M. Am. J. Hum. Genet. (2006) [Pubmed]
  2. Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2. Glaunsinger, B.A., Weiss, R.S., Lee, S.S., Javier, R. EMBO J. (2001) [Pubmed]
  3. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Rai, S.K., Duh, F.M., Vigdorovich, V., Danilkovitch-Miagkova, A., Lerman, M.I., Miller, A.D. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  4. Distinct regions of allelic loss on 13q in prostate cancer. Cooney, K.A., Wetzel, J.C., Merajver, S.D., Macoska, J.A., Singleton, T.P., Wojno, K.J. Cancer Res. (1996) [Pubmed]
  5. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Senchenko, V., Liu, J., Braga, E., Mazurenko, N., Loginov, W., Seryogin, Y., Bazov, I., Protopopov, A., Kisseljov, F.L., Kashuba, V., Lerman, M.I., Klein, G., Zabarovsky, E.R. Oncogene (2003) [Pubmed]
  6. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Ozer, A., Wu, L.C., Bruick, R.K. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  7. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Weinmann, A.S., Bartley, S.M., Zhang, T., Zhang, M.Q., Farnham, P.J. Mol. Cell. Biol. (2001) [Pubmed]
  8. Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Armes, J.E., Hammet, F., de Silva, M., Ciciulla, J., Ramus, S.J., Soo, W.K., Mahoney, A., Yarovaya, N., Henderson, M.A., Gish, K., Hutchins, A.M., Price, G.R., Venter, D.J. Oncogene (2004) [Pubmed]
  9. Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes. Mourtada-Maarabouni, M., Keen, J., Clark, J., Cooper, C.S., Williams, G.T. Exp. Cell Res. (2006) [Pubmed]
  10. Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer. Han, S.Y., Druck, T., Huebner, K. Genomics (2003) [Pubmed]
  11. Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Lutz, M., Burke, L.J., Barreto, G., Goeman, F., Greb, H., Arnold, R., Schultheiss, H., Brehm, A., Kouzarides, T., Lobanenkov, V., Renkawitz, R. Nucleic Acids Res. (2000) [Pubmed]
  12. BAP1, a candidate tumor suppressor protein that interacts with BRCA1. Jensen, D.E., Rauscher, F.J. Ann. N. Y. Acad. Sci. (1999) [Pubmed]
  13. Localization of a second NM23 gene, NME2, to chromosome 17q21-q22. Kelsell, D.P., Black, D.M., Solomon, E., Spurr, N.K. Genomics (1993) [Pubmed]
  14. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Kwong, J., Lee, J.Y., Wong, K.K., Zhou, X., Wong, D.T., Lo, K.W., Welch, W.R., Berkowitz, R.S., Mok, S.C. Neoplasia (2006) [Pubmed]
  15. Genetic and Epigenetic Alterations of DLC-1, a Candidate Tumor Suppressor Gene, in Nasopharyngeal Carcinoma. Peng, D., Ren, C.P., Yi, H.M., Zhou, L., Yang, X.Y., Li, H., Yao, K.T. Acta Biochim. Biophys. Sin. (Shanghai) (2006) [Pubmed]
 
WikiGenes - Universities